Sosei’s Emergency Contraceptive Effective In Phase III
This article was originally published in PharmAsia News
Executive Summary
Sosei's NorLevo (levonorgestrel) proved effective in Japanese women in a new Phase III trial, the Japanese biopharma said July 10. If approved, the drug would become the first emergency contraceptive available in Japan, the company added